Basic Information
| LncRNA/CircRNA Name | RP11-713B9.1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR |
| Sample | NSCLiver Cancer tissues, cell lines(BEAS-2B, H460, H1975, A549) |
| Expression Pattern | down-regulated |
| Function Description | the expression of RP11-713B9.1 was identified to be positively correlated with the expression of tumor suppressors TSLC1, CYLD lysine 63 deubiquitinase and APC WNT signaling pathway regulator, and negatively correlated with B-Raf proto-oncogene serine/threonine kinase expression.the overexpression of RP11-713B9.1 resulted in significant upregulation of TSLC1 and inhibition of H460 cell viability. |
| Pubmed ID | 28765887 |
| Year | 2017 |
| Title | Down-regulation of long noncoding RNA RP11-713B9.1 contributes to the cell viability in non-small cell lung cancer (NSCLC). |
External Links
| Links for RP11-713B9.1 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |